Target intelligence / Profile preview

Acyl-CoA:cholesterol acyltransferase 2 (ACAT2)

Target
ACAT2
Molecular classification
Enzyme, Transferase, Membrane-bound O-acyltransferase (MBOAT) family
01

Overview

Acyl-CoA:cholesterol acyltransferase 2 (ACAT2 or SOAT2) is a membrane-bound enzyme primarily expressed in the small intestine and liver, where it catalyzes the esterification of cholesterol with long-chain fatty acids to form cholesteryl esters. These esters are a key component of lipoprotein particles (especially apoB-containing lipoproteins like VLDL and chylomicrons), playing a crucial role in the absorption and transport of dietary and hepatic cholesterol. ACAT2 activity impacts cholesterol homeostasis, the development of atherosclerotic plaques, and susceptibility to cholesterol gallstone formation. Pharmacological inhibition of ACAT2 is being explored as a therapeutic strategy for atherosclerosis and metabolic disorders. ACAT2 belongs to the membrane-bound O-acyltransferase (MBOAT) enzyme family and has distinct tissue distribution and substrate preferences compared to the related ACAT1 isoform.

Other names
Sterol O-acyltransferase 2SOAT2Acyl-CoA cholesterin acyltransferase 2
02

Mechanism of action

Enzymatic inhibition (inhibitors block cholesterol esterification by ACAT2, reducing cholesterol ester content in lipoproteins and tissues)

03

Biological functions

Cholesterol esterificationLipoprotein assembly (especially apoB-containing lipoproteins)Regulation of cellular cholesterol homeostasisCholesterol absorption in intestineLipid storage
04

Disease associations

AtherosclerosisCardiovascular diseaseGallstone formationDisorders of cholesterol metabolism
05

Safety considerations

Potential for disruption in lipid absorption and metabolismPossibility of liver and intestinal toxicity with strong inhibitionUnintended effects on steroid hormone production and cell membrane composition
06

Interacting drugs

ACAT inhibitors (examples: avasimibe, pactimibe, K-604) [Note: Specific marketed drugs remain limited; most are experimentals or tool compounds]
07

Biomarkers

Plasma cholesteryl ester concentrationIntestinal and hepatic cholesterol absorption ratesFoam cell accumulation in atherosclerotic plaques

Beyond the preview

Go deeper on Acyl-CoA:cholesterol acyltransferase 2 (ACAT2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acyl-CoA:cholesterol acyltransferase 2 (ACAT2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call